Home
Magna Scientia Advanced Biology and Pharmacy
Peer-Reviewed • ISSN: 2582-8363 • Fast-Track Publishing • Impact Factor 8.6 • Low Publication Charges • Crossref DOI Linking

Main navigation

  • Home
    • Journal Information
    • Editorial Board Members
    • Abstracting and Indexing
    • Journal Policies
    • Our CrossMark Policy
    • Publication Ethics
    • Issue in Progress
    • Current Issue
    • Past Issues
    • Instructions for Authors
    • Article processing fee
    • Track Manuscript Status
    • Get Publication Certificate
    • Join Editorial Board
    • Join Reviewer Panel
  • Contact us
  • Downloads

Research and review articles are invited for publication in September - October 2026 (Volume 19, Issue 1) Submit manuscript

Isovitexin, the main phytoconstituent of Anthocleista djalonensis, may be responsible for the plant's antimalarial properties

Breadcrumb

  • Home
  • Isovitexin, the main phytoconstituent of Anthocleista djalonensis, may be responsible for the plant's antimalarial properties

Chika C. Abba 1, *, Mildred C. Egwuatu 1, Onyekachi Johnson 1, Peter M. Eze 3, Nchekwube K. Eze 2 and Onyeka Chinwuba Obidiegwu 1

1 Department of Pharmaceutical and Medicinal Chemistry, Faculty of Pharmaceutical Sciences, Nnamdi Azikiwe University, Anambra State, Nigeria.
2 Department of Pharmaceutical Microbiology and Biotechnology, Faculty of Pharmaceutical Sciences, Nnamdi Azikiwe University, Anambra State, Nigeria.
3 Department of Environmental Health Science, Faculty of Health Sciences and Technology, Nnamdi Azikiwe University, Anambra State, Nigeria.
Research Article
Magna Scientia Advanced Biology and Pharmacy, 2024, 11(02), 026–032
Article DOI: 10.30574/msabp.2024.11.2.0019
DOI url: https://doi.org/10.30574/msabp.2024.11.2.0019
Received on 10 February 2024; revised on 17 March 2024; accepted on 20 March 2024
Several studies have reported on the antimalarial properties of Anthoclestia djalonensis. This study was therefore conducted to validate this report and identify the phytocomponents of the plant that might be responsible for its antimalarial activity. The crude methanol extract of the plant was fractionated into ethyl acetate and n-butanol fractions using the liquid-liquid fractionation method. After a 5-day curative study, the plant's crude extract and fractions at 200 mg/kg showed varying levels of antimalarial properties, with the n-butanol fraction showing the highest parasite clearance (86.8%), followed by the crude extract (77.3%), and the ethyl acetate fraction (49.32%). HPLC analysis of the ethyl acetate and n-butanol fractions revealed isovitexin and its derivative as the plant's major phytoconstituents, and these compounds may be responsible for the plant's antimalarial property.
Anthocleista djalonensis; Isovitexin; HPLC; Plasmodium; Malaria
https://msabp.magnascientiapub.com/sites/default/files/fulltext_pdf/MSABP-2024-…

Preview Article PDF

Chika C. Abba, Mildred C. Egwuatu, Onyekachi Johnson, Peter M. Eze, Nchekwube K. Eze and Onyeka Chinwuba Obidiegwu. Isovitexin, the main phytoconstituent of Anthocleista djalonensis, may be responsible for the plant's antimalarial properties. Magna Scientia Advanced Biology and Pharmacy, 2024, 11(2), 026-032. Article DOI: https://doi.org/10.30574/msabp.2024.11.2.0019

Copyright © Author(s). All rights reserved. This article is published under the terms of the Creative Commons Attribution 4.0 International License (CC BY 4.0), which permits use, sharing, adaptation, distribution, and reproduction in any medium or format, as long as appropriate credit is given to the original author(s) and source, a link to the license is provided, and any changes made are indicated.


All statements, opinions, and data contained in this publication are solely those of the individual author(s) and contributor(s). The journal, editors, reviewers, and publisher disclaim any responsibility or liability for the content, including accuracy, completeness, or any consequences arising from its use.

Get Certificates

Get Publication Certificate

Download LoA

Check Corssref DOI details

Issue details

Issue Cover Page

Editorial Board

Table of content

Copyright © 2026 Magna Scientia Advanced Biology and Pharmacy - All rights reserved

Developed & Designed by VS Infosolution